5-amino-1mq pharmacology 50MG Peptide 5-Amino-1MQ - Phoenix Peptide Labs

doi: 10.3389/fmed.2016.00038 Received 03 July 2016 Accepted 09 August 2016 Published 23 August 2016 Volume 3 - 2016 Edited by Mohammed Morad, Clalit Health Services, Israel Reviewed by Luciana Hannibal, University Medical Center Freiburg, Germany

Phenobarbital in Status epilepticus Rediscovery of an effective drug

Note: Any adverse reactions should be reported via the Yellow Card scheme

Peptides supplied in vials gives flexibility for clinical research methods, as they allow for dosages to be amended depending on intended outcomes of the study

If there is known overdose then treatment is symptomatic & supportive